What dose-fractionation would you recommend for a small basal cell carcinoma of the nasal ala in a patient with poor performance status or transportation difficulties?
Answer from: Radiation Oncologist at Academic Institution
This is a perfect case for high dose limited fractions. I would use 6mV electrons. The smaller the field, the faster you can go. 3 FX per week M-W-F.
350 cGy to 5250
400 cGy to 4800
500 cGy to 4000
600 cGy to 3600
The final stop point determined by response and reaction.
Answer from: Radiation Oncologist at Community Practice
This patient appears to be an excellent candidate for HDR brachytherapy. An appropriately selected surface applicator (Leipzig or Valencia) may be advantageous compared to electrons by allowing for
homogeneous dose distribution to a small area
conformality to an irregular/curved surface
shallow...
Comments
Radiation Oncologist at University Hospitals Case Medical Center Thank you, @Manuj Agarwal. Agreed, those are advan...
Answer from: Radiation Oncologist at Academic Institution
The NCCN guidelines for indolent skin cancers (basal cell carcinoma and squamous cell carcinoma) list four examples of fractionation schedules for definitive treatment of early stage tumors < 2 cm: 64 Gy in 32 fractions over 6 weeks, 55 Gy in 20 fractions over 4 weeks, 50 Gy in 15 fractions over ...
Comments
Radiation Oncologist at Lake Huron Medical Center Thank you. Is the 5 and 7 fraction schemes once pe...
Radiation Oncologist at University Hospitals Case Medical Center The 7 fraction regimen is once per day. The 5 fra...
Radiation Oncologist at Epic Care - Hayward Upto what tumor size would you consider doing the ...
Answer from: Radiation Oncologist at Community Practice
I would suggest several caveats to the above answers.
Electron distributions are unpredictable, particularly on curved surfaces and in small fields. The larger margins required would likely be problematic on a nasal ala, and orthovoltage or HDR brachy would be preferred for fields 3 cm or les...
Comments
Radiation Oncologist at Vice Chair, Northside Hospital Cancer Institute Note that recurrent BCCs or BCCs with either morph...